It’s often said that the only constant is change. Here at the Fogarty Institute, we embrace that sentiment because in the world of medtech, change is inevitable to continue to enhance patient care. That’s why we are delighted with recent advances in funding – while...
Search Results
Q&A With Jeff Elkins, COO of InterVene
Jeff Elkins, a seasoned medtech executive with experience in both startups and larger companies, was recently hired as chief operating officer of InterVene, a Fogarty Institute graduate that has developed a minimally invasive device for the treatment of venous disease...
Mobile Makerspace Concept for Hospitalized, Chronically Ill Patients Is Officially On the Move
What started as a vision to use a mobile makerspace as a tool to inspire young, chronically ill patients to learn, create and innovate – and help make lengthy hospital stays more palatable – is now becoming a reality, thanks to the generous support of Sheri...
J.P. Morgan Healthcare Conference Brings Opportunities As It Hosts a Who’s Who In the Life Sciences Industry
With luminaries such as Joe Biden, Bill Gates and Anne Wojcicki as keynote speakers, the J.P. Morgan Healthcare conference continues to be one of the most prominent events of its kind. This January, it was once again hosted in San Francisco, widely considered one of...
Healyx Changes Lives by Treating Chronic Wounds
Lower-cost, more-effective treatments are the hallmark of many Fogarty Institute companies, and that is the principle Healyx is living up to with its device that provides gold standard care for a chronic problem at a significant cost reduction. Non-healing wounds are...
Q&A With Holly Rockweiler, CEO and Co-Founder of Madorra
A former Stanford Biodesign Fellow and Fogarty Institute entrepreneur, 32-year-old Holly Rockweiler has already had remarkable accomplishments early in her career, fluently moving her startup to the next level. Most notably, Holly has parlayed Madorra’s impressive...
InterVene Makes Strides in Venous Interventional Space
Fogarty Institute graduate InterVene, a startup that has developed a minimally invasive device for the treatment of venous disease in the legs, has treated the 10th patient in their ongoing, multi-center, feasibility study in New Zealand and Australia. Based on the...
New Fogarty Institute Company Lume Medical Developing a Large Bore Vascular Closure Device, a Key Benefit to Cardio Patients
When a cardiovascular intervention is called for, a less-invasive solution is always preferred – which is why percutaneous procedures, such as transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair (EVAR) are on the rise. But this trend hasn’t...
EchoPixel Poised to Revolutionize the Operating Room of the Future
Among the hottest topics in healthcare is the “operating room of the future,” which is on the brink of transformation as new technologies such as artificial intelligence (AI), voice recognition, digital technology and augmented reality are integrated. And at the...
A Better Kind of “Gut Check”
Often referred to as the “second brain,” the gut is garnering increased attention as mounting evidence shows the key role it plays far beyond digesting food in influencing our moods and general health. G-Tech Medical, a Fogarty Institute company, is playing a critical...